Across TCGA pan-cancer cohorts, FAM90A15P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated FAM90A15P data layer.
The strongest signal is observed in brain lower grade glioma (LGG), where higher FAM90A15P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM90A15P expression acts as an unfavorable survival marker.
LGG are the cancer types where FAM90A15P RNA most reproducibly stratifies survival.